Skip to main content
Intestinal microbiome and metabolome signatures in patients with chronic granulomatous disease.
Nasal and blood transcriptomic pathways underpinning the clinical response to grass pollen immunotherapy.
Distinct trajectories distinguish antigen-specific T cells in peanut-allergic individuals undergoing oral immunotherapy.
NFKB2 haploinsufficiency identified via screening for IFNa2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2-related complications.
The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions.
The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 Definitions.
Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: A�randomized controlled trial.
Determinants of lung function across childhood in the Severe Asthma Research Program (SARP) 3.
Aberrant T-cell exhaustion in severe combined immunodeficiency survivors with poor T-cell reconstitution after transplantation.
Recommendations for uniform definitions used in newborn screening for severe combined immunodeficiency.